Heart Disease News and Research

Latest Heart Disease News and Research

Transient ischemic attacks are treatable and preventable

An estimated 200,000 Americans experience TIAs each year, and more than one-third will later have full strokes. But TIAs, like strokes, are treatable and preventable.

29 Oct 2009

Aerobic exercise not only prevents weight gain, but also inhibits regain of harmful visceral fat

A study conducted by exercise physiologists in the University of Alabama at Birmingham (UAB) Department of Human Studies finds that as little as 80 minutes a week of aerobic or resistance training helps not only to prevent weight gain, but also to inhibit a regain of harmful visceral fat one year after weight loss.

29 Oct 2009

Berkeley HeartLab enters into collaborative agreement

Berkeley HeartLab (BHL), a subsidiary of Celera Corporation, announced today that it has entered into collaborative agreements with Geisinger Medical Center and Proven Diagnostics, a clinical laboratory service recently launched by Geisinger Health System.

29 Oct 2009

Sixth round of recipients of Pfizer Cardiovascular Research Awards Program announced

Pfizer Canada is pleased to announce the sixth round of recipients of the Pfizer Cardiovascular Research Awards Program. The program, first launched in October 2005, was developed to fund and support cardiovascular research in Canada.

29 Oct 2009

$5.5 million grant to Cedars-Sinai Heart Institute for development of cardiac stem cell therapies

A team of Cedars-Sinai Heart Institute stem cell researchers led by Eduardo Marbán, M.D., Ph.D. has been awarded a four-year, $5.5 million grant from the California Institute of Regenerative Medicine (CIRM) to fund research leading to clinical trials of new treatments for heart attack patients.

29 Oct 2009

Moores UCSD Cancer Center awarded $20 million for cancer research

Researchers led by Moores UCSD Cancer Center Director Dennis A. Carson, MD, professor of medicine, and Catriona Jamieson, MD, PhD, assistant professor of medicine and director of the Cancer Stem Cell Research Program at the Moores UCSD Cancer Center have been awarded $20 million over four years to develop novel drugs against leukemia stem cells.

28 Oct 2009

CardioNet granted U.S. patent for “Biological Signal Management”

CardioNet, Inc. announced today that the U.S. Patent and Trademark office has granted patent number 7,587,237 (“Biological Signal Management”) to CardioNet. The patent includes certain systems and techniques utilized by the Company’s Mobile Cardiac Outpatient Telemetry™ (MCOT™) system that automatically processes complex physiological information to make it useful for clinical decisions.

28 Oct 2009

iMDsoft and Codonics launch an anesthesia solution with a syringe labeling system

iMDsoft®, a global leader in clinical information systems for perioperative, critical, and acute care, and Codonics of Middleburg Heights, OH, a leading provider of image distribution solutions for the medical industry, have announced an agreement that will complement iMDsoft’s anesthesia solution with an innovative syringe labeling system. The system will be fully integrated with the MetaVision® Anesthesia Information Management System (AIMS).

28 Oct 2009

NeoChord commences patient enrollment in its TACT European clinical trial

NeoChord, Inc., a venture-backed, Minneapolis-based medical technology company, announced today that it has enrolled the first patient in its European clinical trial. The trial, known as TACT (transapical artificial chordae tendineae) is being conducted in Germany, Denmark, Czech Republic and Norway.

28 Oct 2009

Philanthropist gifts $10-million to Sunnybrook Foundation

The people of Ontario will have more access than ever to the latest life-saving, minimally invasive cardiovascular treatments thanks to the visionary leadership of one of Canada's foremost philanthropists, Seymour Schulich.

28 Oct 2009

United States Patent and Trademark Office allows a patent application within ‘Esau’ patent family

Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), and Isis Pharmaceuticals, Inc. (Nasdaq: ISIS), announced today that the United States Patent and Trademark Office (USPTO) has allowed a patent application within the ‘Esau’ patent family (US Application Serial No. 10/909,125).

28 Oct 2009

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

According to new results from the WELCOME trial, exploratory data analyzing the impact of treatment with CIMZIA(®) (certolizumab pegol) - the only PEGylated anti-TNF (alpha) (Tumor Necrosis Factor alpha) - administered either every two weeks or every four weeks, showed that the majority of Crohn's disease patients in both dosing groups experienced no hospitalizations and surgical procedures during the course of the 26-week study.

28 Oct 2009

Third-quarter fiscal 2009 results announced by Neovasc

Neovasc Inc., today announced financial results for the three and nine months ended September 30, 2009.

28 Oct 2009

MEDNAX acquires neonatal group practice in Covington, Louisiana

MEDNAX, Inc., today announced the acquisition of a neonatal group based in Covington, Louisiana, consisting of two physicians who provide neonatal intensive care and well-baby care at St. Tammany Parish Hospital. The hospital’s Level III neonatal intensive care unit (NICU) has annual patient volume in excess of 2,500 patient days.

28 Oct 2009

New CCS guidelines and position papers for physicians and nurse practitioners

Several new guidelines and position papers offering the most up to date information to ensure that clinicians practice evidence-based medicine were released at the Canadian Cardiovascular Congress 2009 this week.

28 Oct 2009

Catheter-directed therapy safe and effective for treating acute pulmonary embolism

William Kuo, MD, was the on-call interventional radiologist one Friday night three years ago when he received a call from the intensive care unit at Stanford Hospital & Clinics. He was asked to attend to a 62-year-old woman who had collapsed at home and was rushed to the emergency room with massive blood clots in her lungs.

28 Oct 2009

Successful partnership between Mercury Therapeutics and CreaGen Biosciences highlighted

The recent licensing deal between Mercury Therapeutics and Debiopharm showcases the highly successful partnership between Mercury Therapeutics and CreaGen Biosciences, said CreaGen in a statement released today.

28 Oct 2009

Onset Medical announces first clinical usage of its Solopath Endovascular Access Catheter

Onset Medical Corporation announced today the first human usage of its SoloPathTM Endovascular Access Catheter in a case performed by Eberhard Grube MD, Chief, Department of Cardiology/Angiology, Helios Heart Center, Siegburg in Germany.

28 Oct 2009

Critical illness insurance, an additional layer of financial protection

As breast cancer awareness month winds to a close and pink ribbons symbolizing the brave fight against this disease take their place on survivors' dressers, the fight continues. Putting the spotlight on this devastating disease has made people think about their own mortality and what would happen if they were diagnosed with a critical illness, says Frank N. Darras, America's top Long Term Disability Lawyer.

28 Oct 2009

Vascular surgeons are endovascularly-trained and have better safety records

Vascular surgeons have the highest market share and the lowest overall mortality and morbidity rates for peripheral arterial interventions (PAI), when compared to interventional cardiologists and interventional radiologists who also perform this procedure.

28 Oct 2009

Heart Disease News and Research

Latest Heart Disease News and Research

Transient ischemic attacks are treatable and preventable

Aerobic exercise not only prevents weight gain, but also inhibits regain of harmful visceral fat

Berkeley HeartLab enters into collaborative agreement

Sixth round of recipients of Pfizer Cardiovascular Research Awards Program announced

$5.5 million grant to Cedars-Sinai Heart Institute for development of cardiac stem cell therapies

Moores UCSD Cancer Center awarded $20 million for cancer research

CardioNet granted U.S. patent for “Biological Signal Management”

iMDsoft and Codonics launch an anesthesia solution with a syringe labeling system

NeoChord commences patient enrollment in its TACT European clinical trial

Philanthropist gifts $10-million to Sunnybrook Foundation

United States Patent and Trademark Office allows a patent application within ‘Esau’ patent family

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

Third-quarter fiscal 2009 results announced by Neovasc

MEDNAX acquires neonatal group practice in Covington, Louisiana

New CCS guidelines and position papers for physicians and nurse practitioners

Catheter-directed therapy safe and effective for treating acute pulmonary embolism

Successful partnership between Mercury Therapeutics and CreaGen Biosciences highlighted

Onset Medical announces first clinical usage of its Solopath Endovascular Access Catheter

Critical illness insurance, an additional layer of financial protection

Vascular surgeons are endovascularly-trained and have better safety records

Pharmaceutical Manufacturing - Industry Focus eBook eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Heart Disease News and Research

Latest Heart Disease News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in